Hyunwoo Cho

Hyunwoo Cho

Auto-generated profile, based on publicly available information

Hyunwoo Cho

The Center for Stem Cell Biology and Developmental Biology program; Memorial Sloan Kettering Cancer Center, New York, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2024 in Nature
Verified
Journal Article
Open access
PDF file
GCGabriele Ciceri
Gabriele Ciceri
ABArianna Baggiolini
Arianna Baggiolini
HCHyein S. Cho
Hyein S. Cho
MKMeghana Kshirsagar
Meghana Kshirsagar
SBSilvia Benito-Kwiecinski
Silvia Benito-Kwiecinski
LSLorenz Studer
Lorenz Studer
The pace of human brain development is highly protracted compared with most other species1–7. The maturation of cortical neurons is particularly slow, taking months to years to develop adult functions3–5. Remarkably, such protracted timing is retained in cortical neurons derived from human pluripotent stem cells (hPSCs) during in vitro differentiation or upon transplantation into the mouse brain4,8,9. Those findings suggest the presence of a cell-intrinsic clock setting the pace of neuronal maturation, although the molecular nature of this clock remains unknown. Here we identify an epigenetic developmental programme that sets the timing of human neuronal maturation. First, we developed a hPSC-based approach to synchronize the birth of cortical neurons in vitro which enabled us to define an atlas of morphological, functional and molecular maturation. We observed a slow unfolding of maturation programmes, limited by the retention of specific epigenetic factors. Loss of function of several of those factors in cortical neurons enables precocious maturation. Transient inhibition of EZH2, EHMT1 and EHMT2 or DOT1L, at progenitor stage primes newly born neurons to rapidly acquire mature properties upon differentiation. Thus our findings reveal that the rate at which human neurons mature is set well before neurogenesis through the establishment of an epigenetic barrier in progenitor cells. Mechanistically, this barrier holds transcriptional maturation programmes in a poised state that is gradually released to ensure the prolonged timeline of human cortical neuron maturation.

4 July 2022 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
DYDapeng Yang
Dapeng Yang
HCHyunwoo Cho
Hyunwoo Cho
ZTZakieh Tayyebi
Zakieh Tayyebi
ASAbhijit Shukla
Abhijit Shukla
RLRenhe Luo
Renhe Luo
DHDanwei Huangfu
Danwei Huangfu

1 October 2021 in Cell Reports
Verified
Journal Article
Open access
SDShanshan Duan
Shanshan Duan
LMLoredana Moro
Loredana Moro
RQRui Qu
Rui Qu
DSDaniele Simoneschi
Daniele Simoneschi
HCHyunwoo Cho
Hyunwoo Cho
MPMichele Pagano
Michele Pagano
FBXO31 is the substrate receptor of one of many CUL1-RING ubiquitin ligase (CRL1) complexes. Here, we show that low FBXO31 mRNA levels are associated with high pre-operative prostate-specific antigen (PSA) levels and Gleason grade in human prostate cancer. Mechanistically, the ubiquitin ligase CRL1FBXO31 promotes the ubiquitylation-mediated degradation of DUSP6, a dual specificity phosphatase that dephosphorylates and inactivates the extracellular-signal-regulated kinase-1 and −2 (ERK1/2). Depletion of FBXO31 stabilizes DUSP6, suppresses ERK signaling, and activates the PI3K-AKT signaling cascade. Moreover, deletion of FBXO31 promotes tumor development in a mouse orthotopic model of prostate cancer. Treatment with BCI, a small molecule inhibitor of DUSP6, suppresses AKT activation and prevents tumor formation, suggesting that the FBXO31 tumor suppressor activity is dependent on DUSP6. Taken together, our studies highlight the relevance of the FBXO31-DUSP6 axis in the regulation of ERK- and PI3K-AKT-mediated signaling pathways, as well as its therapeutic potential in prostate cancer.

5 September 2022 in Development
Verified
Journal Article
Closed access
PDF file
DMDaniel Medina-Cano
Daniel Medina-Cano
ECEmily K. Corrigan
Emily K. Corrigan
RGRachel A. Glenn
Rachel A. Glenn
MIMohammed T. Islam
Mohammed T. Islam
YLYuan Lin
Yuan Lin
TVThomas Vierbuchen
Thomas Vierbuchen
Directed differentiation of pluripotent stem cells (PSCs) is a powerful model system for deconstructing embryonic development. Although mice are the most advanced mammalian model system for genetic studies of embryonic development, state-of-the-art protocols for directed differentiation of mouse PSCs into defined lineages require additional steps and generates target cell types with lower purity than analogous protocols for human PSCs, limiting their application as models for mechanistic studies of development. Here, we examine the potential of mouse epiblast stem cells cultured in media containing Wnt pathway inhibitors as a starting point for directed differentiation. As a proof of concept, we focused our efforts on two specific cell/tissue types that have proven difficult to generate efficiently and reproducibly from mouse embryonic stem cells: definitive endoderm and neural organoids. We present new protocols for rapid generation of nearly pure definitive endoderm and forebrain-patterned neural organoids that model the development of prethalamic and hippocampal neurons. These differentiation models present new possibilities for combining mouse genetic tools with in vitro differentiation to characterize molecular and cellular mechanisms of embryonic development.

17 October 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
BRBess P. Rosen
Bess P. Rosen
QLQing V. Li
Qing V. Li
HCHyein S. Cho
Hyein S. Cho
DLDingyu Liu
Dingyu Liu
DYDapeng Yang
Dapeng Yang
DHDanwei Huangfu
Danwei Huangfu
Pluripotent stem cells have remarkable self-renewal capacity: the ability to proliferate indefinitely while maintaining the pluripotent identity essential for their ability to differentiate into almost any cell type in the body. To investigate the interplay between these two aspects of self-renewal, we perform four parallel genome-scale CRISPR-Cas9 loss-of-function screens interrogating stem cell fitness in hPSCs and the dissolution of primed pluripotent identity during early differentiation. These screens distinguish genes with distinct roles in pluripotency regulation, including mitochondrial and metabolism regulators crucial for stem cell fitness, and chromatin regulators that control pluripotent identity during early differentiation. We further identify a core set of genes controlling both stem cell fitness and pluripotent identity, including a network of chromatin factors. Here, unbiased screening and comparative analyses disentangle two interconnected aspects of pluripotency, provide a valuable resource for exploring pluripotent stem cell identity versus cell fitness, and offer a framework for categorizing gene function.

2 September 2025 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
NXNan Xu
Nan Xu
HCHyein S. Cho
Hyein S. Cho
JHJames O. S. Hackland
James O. S. Hackland
SBSilvia Benito-Kwiecinski
Silvia Benito-Kwiecinski
NSNathalie Saurat
Nathalie Saurat
LSLorenz Studer
Lorenz Studer
Embryonic development follows a conserved sequence of events across species, yet the pace of development is highly variable and particularly slow in humans. Species-specific developmental timing is largely recapitulated in stem cell models, suggesting a cell-intrinsic clock. Here we use directed differentiation of human embryonic stem cells into neuroectoderm to perform a whole-genome CRISPR-Cas9 knockout screen and show that the epigenetic factors Menin and SUZ12 modulate the speed of PAX6 expression during neural differentiation. Genetic and pharmacological loss-of-function of Menin or SUZ12 accelerate cell fate acquisition by shifting the balance of H3K4me3 and H3K27me3 at bivalent promoters, thereby priming key developmental genes for faster activation upon differentiation. We further reveal a synergistic interaction of Menin and SUZ12 in modulating differentiation speed. The acceleration effects were observed in definitive endoderm, cardiomyocyte and neuronal differentiation paradigms, pointing to chromatin bivalency as a general driver of timing across germ layers and developmental stages.